Literature DB >> 25590339

RNA-guided isomerization of uridine to pseudouridine--pseudouridylation.

Yi-Tao Yu1, U Thomas Meier.   

Abstract

Box H/ACA ribonucleoproteins (RNPs), each consisting of one unique guide RNA and 4 common core proteins, constitute a family of complex enzymes that catalyze, in an RNA-guided manner, the isomerization of uridines to pseudouridines (Ψs) in RNAs, a reaction known as pseudouridylation. Over the years, box H/ACA RNPs have been extensively studied revealing many important aspects of these RNA modifying machines. In this review, we focus on the composition, structure, and biogenesis of H/ACA RNPs. We explain the mechanism of how this enzyme family recognizes and specifies its target uridine in a substrate RNA. We discuss the substrates of box H/ACA RNPs, focusing on rRNA (rRNA) and spliceosomal small nuclear RNA (snRNA). We describe the modification product Ψ and its contribution to RNA function. Finally, we consider possible mechanisms of the bone marrow failure syndrome dyskeratosis congenita and of prostate and other cancers linked to mutations in H/ACA RNPs.

Entities:  

Keywords:  DC, dyskeratosis congenita; H/ACA; HH, hoyeraal-hreidarsson syndrome; PIKK, phosphatidylinositol 3-kinase-related kinase; PUA, pseudouridylase and archaeosine transglycosylase; RNA modification; RNA-guided; RNP, ribonucleoprotein; SMN, survival of motor neuron protein; SSD, SHQ1 specific domain; U, uridine; X-DC, X-linked dyskeratosis congenita; dyskeratosis congenita; prostate cancer; pseudouridine; rRNA; rRNA, ribosomal RNA; ribonucleoproteins; sca, small Cajal body; snRNA, small nuclear RNA; sno, small nucleolar; snoRNA; snoRNA, small nucleolar RNA; spliceosomal small nuclear RNA; tRNA, transfer RNA; ψ, pseudouridine, 5-ribosyluracil

Mesh:

Substances:

Year:  2014        PMID: 25590339      PMCID: PMC4615163          DOI: 10.4161/15476286.2014.972855

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  144 in total

1.  Detection and quantitation of RNA base modifications.

Authors:  Xinliang Zhao; Yi-Tao Yu
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

2.  Cbf5p, the putative pseudouridine synthase of H/ACA-type snoRNPs, can form a complex with Gar1p and Nop10p in absence of Nhp2p and box H/ACA snoRNAs.

Authors:  Anthony K Henras; Regine Capeyrou; Yves Henry; Michele Caizergues-Ferrer
Journal:  RNA       Date:  2004-09-23       Impact factor: 4.942

3.  The pseudouridine synthases: revisiting a mechanism that seemed settled.

Authors:  Christopher J Spedaliere; Joy M Ginter; Murray V Johnston; Eugene G Mueller
Journal:  J Am Chem Soc       Date:  2004-10-13       Impact factor: 15.419

4.  "Stem cell" origin of the hematopoietic defect in dyskeratosis congenita.

Authors:  J C Marsh; A J Will; J M Hows; P Sartori; P J Darbyshire; P J Williamson; D G Oscier; T M Dexter; N G Testa
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

5.  Not all pseudouridine synthases are potently inhibited by RNA containing 5-fluorouridine.

Authors:  Christopher J Spedaliere; Eugene G Mueller
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

6.  Nucleotide sequences of 4.5S RNAs associated with poly(A)-containing RNAs of mouse and hamster cells.

Authors:  F Harada; N Kato
Journal:  Nucleic Acids Res       Date:  1980-03-25       Impact factor: 16.971

7.  Genome-wide searching for pseudouridylation guide snoRNAs: analysis of the Saccharomyces cerevisiae genome.

Authors:  Peter Schattner; Wayne A Decatur; Carrie A Davis; Manuel Ares; Maurille J Fournier; Todd M Lowe
Journal:  Nucleic Acids Res       Date:  2004-08-11       Impact factor: 16.971

8.  Properties of a U1/mRNA 5' splice site duplex containing pseudouridine as measured by thermodynamic and NMR methods.

Authors:  K B Hall; L W McLaughlin
Journal:  Biochemistry       Date:  1991-02-19       Impact factor: 3.162

9.  Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins.

Authors:  Chen Wang; U Thomas Meier
Journal:  EMBO J       Date:  2004-03-25       Impact factor: 11.598

10.  GAR1 is an essential small nucleolar RNP protein required for pre-rRNA processing in yeast.

Authors:  J P Girard; H Lehtonen; M Caizergues-Ferrer; F Amalric; D Tollervey; B Lapeyre
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  56 in total

1.  Genome-wide analysis of small nucleolar RNAs of Leishmania major reveals a rich repertoire of RNAs involved in modification and processing of rRNA.

Authors:  Dror Eliaz; Tirza Doniger; Itai Dov Tkacz; Viplov Kumar Biswas; Sachin Kumar Gupta; Nikolay G Kolev; Ron Unger; Elisabetta Ullu; Christian Tschudi; Shulamit Michaeli
Journal:  RNA Biol       Date:  2015-05-13       Impact factor: 4.652

Review 2.  RNA modification in Cajal bodies.

Authors:  U Thomas Meier
Journal:  RNA Biol       Date:  2016-10-24       Impact factor: 4.652

Review 3.  Experience-dependent neural plasticity, learning, and memory in the era of epitranscriptomics.

Authors:  L J Leighton; K Ke; E L Zajaczkowski; J Edmunds; R C Spitale; T W Bredy
Journal:  Genes Brain Behav       Date:  2017-10-20       Impact factor: 3.449

4.  A sensitivity analysis of RNA folding nearest neighbor parameters identifies a subset of free energy parameters with the greatest impact on RNA secondary structure prediction.

Authors:  Jeffrey Zuber; Hongying Sun; Xiaoju Zhang; Iain McFadyen; David H Mathews
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

Review 5.  Epitranscriptomic Code and Its Alterations in Human Disease.

Authors:  Rajashekar Varma Kadumuri; Sarath Chandra Janga
Journal:  Trends Mol Med       Date:  2018-08-14       Impact factor: 11.951

Review 6.  Posttranscriptional RNA Pseudouridylation.

Authors:  Meemanage D De Zoysa; Yi-Tao Yu
Journal:  Enzymes       Date:  2017-03-11

Review 7.  The Evolution of Substrate Specificity by tRNA Modification Enzymes.

Authors:  Katherine M McKenney; Mary Anne T Rubio; Juan D Alfonzo
Journal:  Enzymes       Date:  2017-04-26

Review 8.  Biology and clinical relevance of noncoding sno/scaRNAs.

Authors:  Thuy Cao; Sheeja Rajasingh; Saheli Samanta; Buddhadeb Dawn; Douglas C Bittel; Johnson Rajasingh
Journal:  Trends Cardiovasc Med       Date:  2017-08-12       Impact factor: 6.677

9.  Evolving insights into RNA modifications and their functional diversity in the brain.

Authors:  Sarah Nainar; Paul R Marshall; Christina R Tyler; Robert C Spitale; Timothy W Bredy
Journal:  Nat Neurosci       Date:  2016-09-27       Impact factor: 24.884

10.  Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.

Authors:  Susan E Stanley; Dustin L Gable; Christa L Wagner; Thomas M Carlile; Vidya Sagar Hanumanthu; Joshua D Podlevsky; Sara E Khalil; Amy E DeZern; Maria F Rojas-Duran; Carolyn D Applegate; Jonathan K Alder; Erin M Parry; Wendy V Gilbert; Mary Armanios
Journal:  Sci Transl Med       Date:  2016-08-10       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.